Clinical Trial Update: Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy [Phase 1]

View source ↗

Summary

Phase I/II combination chemotherapy trial for lung cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2019-02-01